Search

Your search keyword '"Corsico A.G."' showing total 31 results

Search Constraints

Start Over You searched for: Author "Corsico A.G." Remove constraint Author: "Corsico A.G."
31 results on '"Corsico A.G."'

Search Results

1. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

8. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

9. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

10. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes

11. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

13. Exacerbations as a starting point of pro-active chronic obstructive pulmonary disease management

14. The Association of Self-Reported Birthweight with Lung Function and Respiratory Diseases: Results from a Multi-Centre, Multi-Case Control Study in Italy

15. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

16. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

17. Gastritis and gastroesophageal reflux disease are strongly associated with non-allergic nasal disorders

18. Suggestions for lung function testing in the context of COVID-19

19. Exploring the Relationship between Disease Awareness and Outcomes in Patients with Chronic Obstructive Pulmonary Disease

20. COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments

21. Severe asthma: One disease and multiple definitions

22. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

23. Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution

24. What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis

25. Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?

26. The prevalence of sleep impairments and predictors of sleep quality among patients with asthma

27. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

28. Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study

29. Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT)study follow-up

30. Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study

31. Corrigendum to 'Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up' (Respiratory Medicine (2019) 153 (68–75), (S0954611119301763), (10.1016/j.rmed.2019.05.017))

Catalog

Books, media, physical & digital resources